Status:
NOT_YET_RECRUITING
Study of Exercise Capacity and Physical Activity in Children With Congenital Heart Disease
Lead Sponsor:
University of Ulster
Collaborating Sponsors:
Belfast Health and Social Care Trust
Conditions:
Congenital Heart Disease
Eligibility:
All Genders
5-18 years
Phase:
NA
Brief Summary
Congenital heart disease (CHD) is the most common birth defect worldwide and occurs in every 8-10 per 1000 live births in Northern Ireland. The ability to participate in physical activity (PA) is an i...
Detailed Description
WHY THIS RESEARCH MATTERS The ability to take part in PA is an important aspect to an individual's quality of life. The UK Chief Medical Officer currently recommends that children aged 5-18 years shou...
Eligibility Criteria
Inclusion
- Children with congenital heart disease aged 5-18 years (all diagnoses).
- Children with congenital heart disease aged 5-18 years and an intellectual disability.
Exclusion
- Children or parents/guardians who do not wish to give assent or consent to participate in this study.
- Children with an underlying health condition and or physical disability in addition to congenital heart disease, to minimize the risk of confounding variables.
Key Trial Info
Start Date :
May 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06945003
Start Date
May 15 2025
End Date
June 30 2026
Last Update
April 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Belfast Hospital for Sick Children
Belfast, United Kingdom